Fludarabine trials for Ovarian Cancer

All Fludarabine trials · All Ovarian Cancer trials

Phase breakdown

Recruiting trials studying Fludarabine for Ovarian Cancer

• A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies
  NCT07613723 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
  NCT02830724 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 1 location
• Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
  NCT03412877 · Phase: Phase 2 · Ages: 18 Years to 72 Years · Sex: All (male and female) · 2 locations

Common questions

How many trials study Fludarabine for Ovarian Cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.